Home

FHM VI, L.L.C.

CIK 1456654 · last filed 2017-11-06

FHM VI, L.L.C. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2012. The most recent filing, for ALNA, was dated Nov 6, 2017. Across all open-market trades the lifetime net is −$229.3M, making them a net seller over the disclosed history. The firm reports its address in Seattle, WA. 12 SEC filings were submitted jointly with FHM VI, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

3

Lifetime Open-Market Net

-$229.32M

Filer Profile

Reported Address
601 UNION STREET, SUITE 3200
SEATTLE, WA 98101
Phone
(206) 621-7200
State of Incorporation
DE
Related Filers
FHM VI, L.P. — 12 joint filings, latest 2018-12-11
Nathan R Every — 3 joint filings, latest 2017-02-24
ALAN D FRAZIER — 3 joint filings, latest 2017-02-24
Nader J Naini — 3 joint filings, latest 2017-02-24
James N Topper — 2 joint filings, latest 2015-05-14
FHM LIFE SCIENCES VIII, L.L.C. — 1 joint filings, latest 2017-02-24
FHM V, LLC — 1 joint filings, latest 2009-02-20
FHM V, LP — 1 joint filings, latest 2009-02-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Allena Pharmaceuticals, Inc. (ALNA) Delisted 10%+ Owner 2,830,373 $0.07 $212.3K $21.00M 1 2017-11-06
Molecular Templates, Inc. (THLD) Delisted 10%+ Owner 645,498 — — -$250.32M 2 2012-02-23

Recent Filings

3 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-11-06 Allena Pharmaceuticals, Inc. (ALNA) Delisted Mixed +9,991,119 $21.00M EDGAR
2012-02-23 Molecular Templates, Inc. (THLD) Delisted Sell (S) −41,211,729 -$242.17M EDGAR
2012-02-08 Molecular Templates, Inc. (THLD) Delisted Sell (S) −2,700,000 -$8.15M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.